Skip to main content
Top
Literature
1.
go back to reference Sanchez-Armengol A, Villalobos-Lopez P, Caballero-Eraso C, Carmona-Bernal C, Asensio-Cruz M, Barbe F, Capote F (2015) Gamma glutamyl transferase and oxidative stress in obstructive sleep apnea: a study in 1744 patients. Sleep Breath. doi:10.1007/s11325-014-1115-5 Sanchez-Armengol A, Villalobos-Lopez P, Caballero-Eraso C, Carmona-Bernal C, Asensio-Cruz M, Barbe F, Capote F (2015) Gamma glutamyl transferase and oxidative stress in obstructive sleep apnea: a study in 1744 patients. Sleep Breath. doi:10.​1007/​s11325-014-1115-5
2.
go back to reference Stein MD, Friedmann PD (2005) Disturbed sleep and its relationship to alcohol use. Subst Abus 26(1):1–13 Stein MD, Friedmann PD (2005) Disturbed sleep and its relationship to alcohol use. Subst Abus 26(1):1–13
3.
go back to reference Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3(4):310–318 Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3(4):310–318
Metadata
Title
Serum gamma glutamyl transferase in patients with sleep apnea-hypopnea
Author
Tomoyuki Kawada
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 1/2016
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1222-y

Other articles of this Issue 1/2016

Sleep and Breathing 1/2016 Go to the issue

Sleep Breathing Physiology and Disorders • Letter to the Editors

Efficacy of EPAP

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine